Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-10 · accession 0001773751-25-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-11 | 2025-02-10 | HIMS | Okupe Oluyemi | CFO | S - Sale+OE | $43.01 | -11.6K | 110.2K | -10% | -$498.1K |
| D | 2025-02-11 | 2025-02-10 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $5.01 | +6,437 | 119.4K | +6% | +$32.2K |
| D | 2025-02-11 | 2025-02-10 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $0.00 | -6,437 | 413.3K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-10 | S | D | 997 | $43.23 | 107,789 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $43.18 - $43.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2025-02-10 | S | D | 1,391 | $43.21 | 108,786 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $43.12 - $43.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2025-02-10 | S | D | 9,193 | $42.96 | 110,177 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $42.59 - $43.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Class A Common Stock | 2025-02-10 | M | A | 6,437 | $5.01 | 119,370 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2025-02-10 | M | D | 6,437 | $0.00 | 413,300 | D | $5.01 · — to 2032-02-23 | 6,437 Class A Common Stock | (F5) 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. |